#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11222	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2179	508.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1418	1418	C	656	C,T	632,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11222	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2179	508.0	0	HET	.	.	.	C207T,G	.	207	207	C	441	441	C	652	C,T,G	334,284,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20772	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3583	573.9	0	.	n	.	0	T695C	SNP	695	695	T	1030	1030	C	641	C	624	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20772	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3583	573.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2306	2306	C	617	C	600	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20772	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3583	573.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2380	2380	A	613	A	599	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20772	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3583	573.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2932	2932	C	645	C	629	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20772	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3583	573.9	0	HET	.	.	.	A1638G	.	1638	1638	A	1973	1973	A	641	A,G	474,149	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1486	folP	855	855	100.0	folP.l15.c4.ctg.1	1688	87.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1185	1187	AGC	144;146;145	A;G;C	138;139;137	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4530	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3407	131.6	1	SNP	p	S91F	1	.	.	271	273	TTC	582	584	TTC	165;164;162	T;T;C	159;161;156	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4530	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3407	131.6	1	SNP	p	D95G	1	.	.	283	285	GGC	594	596	GGC	157;155;155	G;G;C	152;152;151	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4530	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3407	131.6	1	SNP	p	G95N	0	.	.	283	285	GGC	594	596	GGC	157;155;155	G;G;C	152;152;151	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1194	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1389	85.1	1	SNP	p	G45D	0	.	.	133	135	GGC	433	435	GGC	141;140;141	G;G;C	137;137;137	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	644	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	992	64.4	0	.	n	.	0	A197.	DEL	197	197	A	570	570	A	138	A	137	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3876	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2994	128.3	1	SNP	p	D86N	0	.	.	256	258	GAC	640	642	GAC	138;137;138	G;A;C	135;131;136	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3876	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2994	128.3	1	SNP	p	R87I	0	.	.	259	261	CGT	643	645	CGT	137;141;141	C,G,A;G;T	134,1,1;138;133	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3876	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2994	128.3	1	SNP	p	R87W	0	.	.	259	261	CGT	643	645	CGT	137;141;141	C,G,A;G;T	134,1,1;138;133	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3876	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2994	128.3	1	SNP	p	S87R	1	.	.	259	261	CGT	643	645	CGT	137;141;141	C,G,A;G;T	134,1,1;138;133	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3876	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2994	128.3	1	SNP	p	S88P	0	.	.	262	264	TCC	646	648	TCC	141;141;141	T;C;C	133;136;137	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3010	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2647	112.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1619	1621	GGC	151;150;149	G;G;C	144;144;139	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3046	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2353	127.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1195	1197	GCC	160;160;158	G;C;C	153;158;155	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3046	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2353	127.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1198	1200	ATG	156;156;157	A;T;G	154;153;152	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3046	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2353	127.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1210	1212	ACC	170;171;172	A;C;C	163;170;170	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3046	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2353	127.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1210	1212	ACC	170;171;172	A;C;C	163;170;170	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3046	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2353	127.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1711	1713	ACC	147;149;153	A,C;C;C	138,1;145;149	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3046	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2353	127.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1765	1767	GCG	163;160;163	G;C;G	160;158;159	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3046	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2353	127.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1765	1767	GCG	163;160;163	G;C;G	160;158;159	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3046	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2353	127.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1888	1890	GGT	121;120;119	G;G;T	118;116;116	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3046	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2353	127.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1897	1899	AGC	115;116;115	A;G,C;C	109;110,1;109	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3046	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2353	127.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1915	1917	CCG	91;90;87	C;C;G,C	83;81;69,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4428	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3165	138.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1677	1679	CCG	169;165;168	C;C;G,C	147;156;149,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1954	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1706	113.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	547	547	C	132	C	125	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	319	17.5	0	.	p	.	0	A251V	NONSYN	751	753	GCG	76	78	GTA	19;19;19	G;T;A	18;18;18	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	319	17.5	0	.	p	.	0	S271T	NONSYN	811	813	TCG	136	138	ACT	32;32;31	A;C;T	30;30;30	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	319	17.5	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	142	144	GAT	24;24;24	G;A;T	24;24;22	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	319	17.5	0	.	p	.	0	D276N	NONSYN	826	828	GAT	151	153	AAC	25;25;25	A;A;C	25;24;25	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	319	17.5	0	.	p	.	0	N277H	NONSYN	829	831	AAC	154	156	CAC	25;25;25	C;A;C	25;24;25	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	319	17.5	0	.	p	.	0	R307E	NONSYN	919	921	AGA	244	246	GAA	10;10;11	G;A;A	10;10;11	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	319	17.5	0	.	p	.	0	T311A	NONSYN	931	933	ACA	256	258	GCA	11;11;11	G;C;A	11;11;11	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	319	17.5	0	.	p	.	0	E312D	NONSYN	934	936	GAA	259	261	GAC	11;10;10	G;A;C	11;10;10	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	319	17.5	0	.	p	.	0	F314I	NONSYN	940	942	TTC	265	267	ATC	10;9;9	A;T;C	10;9;9	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	319	17.5	0	.	p	.	0	A316S	NONSYN	946	948	GCG	271	273	TCG	9;9;9	T;C;G	9;9;8	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	319	17.5	0	.	p	.	0	V318A	NONSYN	952	954	GTC	277	279	GCC	8;8;8	G;C;C	7;8;7	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	319	17.5	0	.	p	.	0	G319S	NONSYN	955	957	GGC	280	282	AGC	8;8;8	A;G;C	7;8;8	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	319	17.5	0	.	p	.	0	G320A	NONSYN	958	960	GGT	283	285	GCC	9;8;8	G;C;C	8;8;7	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	319	17.5	0	.	p	.	0	G322V	NONSYN	964	966	GGT	289	291	GTT	8;8;8	G;T;T	7;8;7	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2018	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1487	134.3	0	.	p	.	0	I45V	NONSYN	133	135	ATT	373	375	GTT	165;164;166	G;T;T	161;160;162	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2018	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1487	134.3	0	.	p	.	0	G210R	NONSYN	628	630	GGA	868	870	AGA	157;157;155	A;G;A	154;148;148	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2018	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1487	134.3	0	.	p	.	0	G252E	NONSYN	754	756	GGA	994	996	GAA	145;147;149	G,T;A,T;A	143,1;145,1;148	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2018	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1487	134.3	1	SNP	p	G120K	1	.	.	358	360	AAG	598	600	AAG	139;143;144	A,C;A;G,A	134,1;138;133,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2018	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1487	134.3	1	SNP	p	A121N	1	.	.	361	363	AAC	601	603	AAC	144;144;142	A;A;C	139;140;136	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2018	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1487	134.3	1	SNP	p	N121D	0	.	.	361	363	AAC	601	603	AAC	144;144;142	A;A;C	139;140;136	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7498	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4874	152.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	894	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1084	81.7	1	SNP	p	V57M	1	.	.	169	171	ATG	519	521	ATG	186;187;187	A;T;G	184;184;184	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
